We are live on
!
Find out more
Esperion Therapeutics
ESPR
ESPR
200 hedge funds and large institutions have $560M invested in Esperion Therapeutics in 2025 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 83 increasing their positions, 34 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
350% more call options, than puts
Call options by funds: $19.2M | Put options by funds: $4.26M
144% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 34
96% more capital invested
Capital invested by funds: $286M → $560M (+$274M)
54% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 28
9.73% more ownership
Funds ownership: 53.55% → 63.28% (+9.7%)
6% more funds holding
Funds holding: 188 → 200 (+12)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
200
Holders Change
+12
Holders Change %
+6.38%
% of All Funds
2.43%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
43
Increased
83
Reduced
34
Closed
28
Calls
$19.2M
Puts
$4.26M
Net Calls
+$14.9M
Net Calls Change
+$14.6M
Top Buyers
| 1 |
D.E. Shaw & Co
New York
|
+$21.6M |
| 2 |
O
OrbiMed
New York
|
+$19.3M |
| 3 |
EP
Eversept Partners
New York
|
+$12.4M |
| 4 |
Millennium Management
New York
|
+$9.56M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$9.53M |
Top Sellers
| 1 |
PCM
PenderFund Capital Management
Vancouver,
British Columbia, Canada
|
-$7.38M |
| 2 |
IHAM
Integral Health Asset Management
New York
|
-$3.98M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$3.01M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.91M |
| 5 |
Jane Street
New York
|
-$2.82M |
